secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001104659-23-082414
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents appoints Alexander D'Amico as CFO effective August 7, 2023
-----------------------------------------------------------------------

- Annual base salary of $425,000; eligible for cash bonus up to 45% of salary based on milestones.
- Received signing bonus of $5,000 and equity awards including 70,000 ISOs, 45,000 RSUs, 215,000 performance ISOs.
- Employment agreement initial term through Dec 31, 2025, auto-renewing annually thereafter.
- D'Amico previously CFO of Trulieve Cannabis; oversaw finance during revenue growth from $250M to $1.2B.
- Outgoing CFO Kathy Bloch retiring after decade of service; transition managed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/0001104659-23-082414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/tm2321613d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-082414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer